BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24525737)

  • 21. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP
    Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
    Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
    PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
    Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
    EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
    BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
    Iwanami A; Gini B; Zanca C; Matsutani T; Assuncao A; Nael A; Dang J; Yang H; Zhu S; Kohyama J; Kitabayashi I; Cavenee WK; Cloughesy TF; Furnari FB; Nakamura M; Toyama Y; Okano H; Mischel PS
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4339-44. PubMed ID: 23440206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.
    Mathieu MG; Knights AJ; Pawelec G; Riley CL; Wernet D; Lemonnier FA; Straten PT; Mueller L; Rees RC; McArdle SE
    Cancer Immunol Immunother; 2007 Dec; 56(12):1885-95. PubMed ID: 17487488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells.
    Laner-Plamberger S; Wolff F; Kaser-Eichberger A; Swierczynski S; Hauser-Kronberger C; Frischauf AM; Eichberger T
    PLoS One; 2013; 8(9):e75317. PubMed ID: 24058673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.
    Chatterjee A; Chatterjee U; Ghosh MK
    Cell Death Dis; 2013 Mar; 4(3):e543. PubMed ID: 23492774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
    Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
    PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
    Hubackova S; Krejcikova K; Bartek J; Hodny Z
    J Biol Chem; 2012 Aug; 287(32):26702-14. PubMed ID: 22711534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.